Explore new and improved GeneGlobe! Access the most comprehensive NGS, PCR and functional analysis portfolio coupled to manually curated, interlinked data on more than 10,000 biological entities – from miRNAs and genes to pathways.

RNA-seq can be challenging if working with RNA derived from FFPE samples. Read the story of Dr. Fabienne Desmots-Loyer at the Hospital Rennes. Discover how QIAseq FastSelect rRNA removal technology transformed her research by providing high-quality libraries from FFPE tumor samples previously rejected for processing by two commercial labs due to high levels of RNA degradation and low yields.

QIAGEN’s gold-standard latent TB test, QuantiFERON-TB Gold Plus, has been added to the Global Drug Facility catalog of the Stop TB Partnership. The new endorsement will expand the availability of the modern blood-test in regions with a high disease burden but limited resources.

QIAGEN and Illumina partner to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits. Read the full press release here.

A new study reinforces the utility of liquid biopsy to identify clinically actionable mutations and guide clinical trial enrollment for patients with advanced cancer. Download your copy of the paper.